Institutional investors purchased a net $1.2 million shares of EBS during the quarter ended June 2014. This may signal that the smart money is gaining interest in this company as the 77.83% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 502.5 Thousand shares of Emergent BioSolutions Inc